Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines

Todd,Maria  C.; Petty,Heather  M.; King,Jonathan  M.; Piana Marshall,Brytanie  N.; Sheller,Rebecca  A.; Cuevas,Maria  E.

doi:10.3892/ol.2015.3160

July-2015 Volume 10 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2015 Volume 10 Issue 1

Full Size Image

Article Open Access

Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines

Authors:
- Maria C. Todd
- Heather M. Petty
- Jonathan M. King
- Brytanie N. Piana Marshall
- Rebecca A. Sheller
- Maria E. Cuevas
View Affiliations / Copyright

Affiliations: Biology Department, Southwestern University, Georgetown, TX 78626, USA, Biology Department, Trinity University, San Antonio, TX 78212, USA

Copyright: © Todd et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 156-162
|
Published online on: April 28, 2015

https://doi.org/10.3892/ol.2015.3160
Expand metrics +

Abstract

Tumor-specific deregulated expression of claudins, integral membrane proteins found in tight junctions (TJs), has indicated a possible role for TJ disruption in cancer progression. The current study demonstrates the marked overexpression of claudin‑3 protein in two breast cancer cell lines of metastatic origin (MCF-7 and MDA-MB-415). Immunofluorescence and differential detergent fractionation analyses revealed that, although claudin‑3 was primarily localized at cell junctions, it was also detected intracellularly. Similarly, the siRNA‑mediated suppression of claudin‑3 did not considerably affect its pattern of subcellular distribution relative to mock‑transfected cells. However, there appeared to be a preferential loss of claudin‑3 signal in the cytoskeletal fraction. Wound‑healing assays were conducted to assess the effect of endogenous overexpression versus siRNA‑mediated suppression of claudin‑3 on cellular motility in MCF‑7 cells. Suppression of claudin‑3 protein levels resulted in a marked decrease in the rate of cellular motility relative to mock‑transfected cells. These findings suggest that overexpression of claudin‑3 may be important in disrupting TJ integrity and thus contribute to enhanced cellular motility, a key component of tumor progression.

View Figures

View References

1	American Cancer Society, . Breast Cancer Facts & Figures. http://www.cancer.org/research/cancerfactsstatistics/breast-cancer-facts-figuresAccessed. February 24–2014
2	Turksen K and Troy TC: Barriers built on claudins. J Cell Sci. 117:2435–2447. 2004. View Article : Google Scholar : PubMed/NCBI
3	Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P and Sukumar S: Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol. 164:1627–1633. 2004. View Article : Google Scholar : PubMed/NCBI
4	Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J, et al: Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer. 124:2088–2097. 2009. View Article : Google Scholar : PubMed/NCBI
5	Tokés AM, Kulka J, Paku S, Szik A, Páska C, Novák PK, Szilák L, Kiss A, Bögi K and Schaff Z: Claudin-1, −3 and −4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 7:R296–R305. 2005. View Article : Google Scholar : PubMed/NCBI
6	Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal and carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003. View Article : Google Scholar : PubMed/NCBI
7	Tokés AM, Kulka J, Paku S, Máthé M, Páska C, Lódi C..Kiss A and Schaff Z: The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathol Res Pract. 201:537–544. 2005. View Article : Google Scholar : PubMed/NCBI
8	Agarwal R, D'Souza T and Morin PJ: Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 65:7378–7385. 2005. View Article : Google Scholar : PubMed/NCBI
9	Oku N, Sasabe E, Ueta E, Yamamoto T and Osaki T: Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 66:5251–5257. 2006. View Article : Google Scholar : PubMed/NCBI
10	Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK and Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 115:1765–1776. 2005. View Article : Google Scholar : PubMed/NCBI
11	Pan XY, Wang B, Che YC, Weng ZP, Dai HY and Peng W: Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int J Gynecol Cancer. 17:233–241. 2007. View Article : Google Scholar : PubMed/NCBI
12	Konecny GE, Agarwal R, Keeney GA, Winterhoff B, Jones MB, Mariani A, et al: Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometroid endometrial cancer. Gynecol Oncol. 109:263–269. 2008. View Article : Google Scholar : PubMed/NCBI
13	French AD, Fiori JL, Camilli TC, Leotlela PD, O'Connell MP, Frank BP, Subaran S, Indig FE, Taub DD and Weeraratna AT: PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci. 6:93–101. 2009.PubMed/NCBI
14	Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, et al: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 63:6265–6271. 2003.PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles